Bard Associates’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $44K | Sell |
|
|||||
|
2019
Q4 | $87K | Sell |
|
|||||
|
2019
Q3 | $91K | Sell |
|
|||||
|
2019
Q2 | $176K | Sell |
|
|||||
|
2019
Q1 | $291K | Sell |
|
|||||
|
2018
Q4 | $316K | Sell |
|
|||||
|
2018
Q3 | $521K | Sell |
|
|||||
|
2018
Q2 | $486K | Sell |
|
|||||
|
2018
Q1 | $535K | Buy |
|
|||||
|
2017
Q4 | $665K | Sell |
|
|||||
|
2017
Q3 | $790K | Sell |
|
|||||
|
2017
Q2 | $796K | Hold |
|
|||||
|
2017
Q1 | $650K | Sell |
|
|||||
|
2016
Q4 | $491K | Sell |
|
|||||
|
2016
Q3 | $542K | Sell |
|
|||||
|
2016
Q2 | $445K | Sell |
|
|||||
|
2016
Q1 | $1M | Sell |
|
|||||
|
2015
Q4 | $885K | Sell |
|
|||||
|
2015
Q3 | $677K | Sell |
|
|||||
|
2015
Q2 | $742K | Sell |
|
|||||
|
2015
Q1 | $710K | Sell |
|
|||||
|
2014
Q4 | $1.12M | Buy |
|
|||||
|
2014
Q3 | $822K | Sell |
|
|||||
|
2014
Q2 | $847K | Buy |
|
|||||
|
2014
Q1 | $1.09M | Hold |
|
|||||
|
2013
Q4 | $1.09M | Buy |
|